|
1
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Subramanian S, Geng H and Tan XD: Cell
death of intestinal epithelial cells in intestinal diseases. Sheng
Li Xue Bao. 72:308–324. 2020.PubMed/NCBI
|
|
3
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su LJ, Zhang JH, Gomez H, Murugan R, Hong
X, Xu D, Jiang F and Peng ZY: Reactive oxygen species-induced lipid
peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med
Cell Longev. 2019:50808432019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vanden Berghe T, Linkermann A,
Jouan-Lanhouet S, Walczak H and Vandenabeele P: Regulated necrosis:
The expanding network of non-apoptotic cell death pathways. Nat Rev
Mol Cell Biol. 15:135–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirschhorn T and Stockwell BR: The
development of the concept of ferroptosis. Free Radic Biol Med.
133:130–143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Sui S, Wang L, Li H, Zhang L, Xu
S and Zheng X: Inhibition of tumor propellant glutathione
peroxidase 4 induces ferroptosis in cancer cells and enhances
anticancer effect of cisplatin. J Cell Physiol. 235:3425–3437.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deans C and Maggert KA: What do you mean,
‘epigenetic’? Genetics. 199:887–896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu J, Xiong Y, Zhang Y, Wen J, Cai N,
Cheng K, Liang H and Zhang W: The molecular mechanisms of
regulating oxidative stress-induced ferroptosis and therapeutic
strategy in tumors. Oxid Med Cell Longev. 2020:88107852020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei Y, Lv H, Shaikh AB, Han W, Hou H,
Zhang Z, Wang S and Shang P: Directly targeting glutathione
peroxidase 4 may be more effective than disrupting glutathione on
ferroptosis-based cancer therapy. Biochim Biophys Acta Gen Subj.
1864:1295392020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang X, Wang H, Han D, Xie E, Yang X, Wei
J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for
protection against cardiomyopathy. Proc Natl Acad Sci USA.
116:2672–2680. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bogdan AR, Miyazawa M, Hashimoto K and
Tsuji Y: Regulators of iron homeostasis: New players in metabolism,
cell death, and disease. Trends Biochem Sci. 41:274–286. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Anderson CP, Shen M, Eisenstein RS and
Leibold EA: Mammalian iron metabolism and its control by iron
regulatory proteins. Biochim Biophys Acta. 1823:1468–1483. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kato J, Kobune M, Ohkubo S, Fujikawa K,
Tanaka M, Takimoto R, Takada K, Takahari D, Kawano Y, Kohgo Y and
Niitsu Y: Iron/IRP-1-dependent regulation of mRNA expression for
transferrin receptor, DMT1 and ferritin during human erythroid
differentiation. Exp Hematol. 35:879–887. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bolotta A, Abruzzo PM, Baldassarro VA,
Ghezzo A, Scotlandi K, Marini M and Zucchini C: New insights into
the hepcidin-ferroportin axis and iron homeostasis in iPSC-derived
cardiomyocytes from friedreich's ataxia patient. Oxid Med Cell
Longev. 2019:76230232019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao G, Li J, Zhang Y and Chang YZ:
Cellular iron metabolism and regulation. Adv Exp Med Biol.
1173:21–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arruda SF, Ramos LV, Barbosa JLA, Hankins
NAC, Rodrigues PAM and Cunha MSBD: The action of JAK/STAT3 and
BMP/HJV/SMAD signaling pathways on hepcidin suppression by
tucum-do-cerrado in a normal and iron-enriched diets. Nutrients.
12:15152020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Babitt JL, Huang FW, Wrighting DM, Xia Y,
Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, et
al: Bone morphogenetic protein signaling by hemojuvelin regulates
hepcidin expression. Nat Genet. 38:531–539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu PB, Hong CC, Sachidanandan C, Babitt
JL, Deng DY, Hoyng SA, Lin HY, Bloch KD and Peterson RT:
Dorsomorphin inhibits BMP signals required for embryogenesis and
iron metabolism. Nat Chem Biol. 4:33–41. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Truksa J, Lee P and Beutler E: Two BMP
responsive elements, STAT, and bZIP/HNF4/COUP motifs of the
hepcidin promoter are critical for BMP, SMAD1, and HJV
responsiveness. Blood. 113:688–695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Srole DN and Ganz T: Erythroferrone
structure, function, and physiology: Iron homeostasis and beyond. J
Cell Physiol. 236:4888–4901. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duan L, Yin X, Meng H, Fang X, Min J and
Wang F: Progress on epigenetic regulation of iron homeostasis.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 49:58–70. 2020.(In Chinese).
PubMed/NCBI
|
|
24
|
Patnaik MM and Tefferi A: Myelodysplastic
syndromes with ring sideroblasts (MDS-RS) and
MDS/myeloproliferative neoplasm with RS and thrombocytosis
(MDS/MPN-RS-T)-‘2021 update on diagnosis, risk-stratification, and
management’. Am J Hematol. 96:379–394. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rawat PS, Jaiswal A, Khurana A, Bhatti JS
and Navik U: Doxorubicin-induced cardiotoxicity: An update on the
molecular mechanism and novel therapeutic strategies for effective
management. Biomed Pharmacother. 139:1117082021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blackledge NP and Klose R: CpG island
chromatin: A platform for gene regulation. Epigenetics. 6:147–152.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Illingworth RS, Gruenewald-Schneider U,
Webb S, Kerr AR, James KD, Turner DJ, Smith C, Harrison DJ, Andrews
R and Bird AP: Orphan CpG islands identify numerous conserved
promoters in the mammalian genome. PLoS Genet. 6:e10011342010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grand RS, Burger L, Gräwe C, Michael AK,
Isbel L, Hess D, Hoerner L, Iesmantavicius V, Durdu S, Pregnolato
M, et al: BANP opens chromatin and activates CpG-island-regulated
genes. Nature. 596:133–137. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maunakea AK, Nagarajan RP, Bilenky M,
Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C,
Zhao Y, et al: Conserved role of intragenic DNA methylation in
regulating alternative promoters. Nature. 466:253–257. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Horvath S and Raj K: DNA methylation-based
biomarkers and the epigenetic clock theory of ageing. Nat Rev
Genet. 19:371–384. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye Q, Trivedi M, Zhang Y, Böhlke M,
Alsulimani H, Chang J, Maher T, Deth R and Kim J: Brain iron
loading impairs DNA methylation and alters GABAergic function in
mice. FASEB J. 33:2460–2471. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Macková E, Hrušková K, Bendová P, Vávrová
A, Jansová H, Hašková P, Kovaříková P, Vávrová K and Simůnek T:
Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl
hydrazone: Novel iron chelators with selective antiproliferative
action. Chem Biol Interact. 197:69–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang WC, Lin SF, Wang SC, Tsai WC, Wu CC
and Wu SC: The effects of human BDH2 on the cell cycle,
differentiation, and apoptosis and associations with leukemia
transformation in myelodysplastic syndrome. Int J Mol Sci.
21:30332020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma S, Henson ES, Chen Y and Gibson SB:
Ferroptosis is induced following siramesine and lapatinib treatment
of breast cancer cells. Cell Death Dis. 7:e23072016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kajarabille N and Latunde-Dada GO:
Programmed cell-death by ferroptosis: Antioxidants as mitigators.
Int J Mol Sci. 20:49682019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao J, Luo T and Wang J: Gene
interfered-ferroptosis therapy for cancers. Nat Commun.
12:53112021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang F, Wang J, Shen Y, Li H, Rausch WD
and Huang X: Iron dyshomeostasis and ferroptosis: A new Alzheimer's
disease hypothesis? Front Aging Neurosci. 14:8305692022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Y, Zhang S, Wang X, Guo W, Wang L,
Zhang D, Yuan L, Zhang Z, Xu Y and Liu S: Disordered signaling
governing ferroportin transcription favors breast cancer growth.
Cell Signal. 27:168–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Udali S, Castagna A, Corbella M,
Ruzzenente A, Moruzzi S, Mazzi F, Campagnaro T, De Santis D,
Franceschi A, Pattini P, et al: Hepcidin and DNA promoter
methylation in hepatocellular carcinoma. Eur J Clin Invest.
48:e128702018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Al-Amer O and Alsharif KF: Frequency of
the HAMP (c.-582 A>G) polymorphism in iron deficiency in Saudi
Arabia. Pak J Biol Sci. 24:146–150. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sies H: Oxidative stress: A concept in
redox biology and medicine. Redox Biol. 4:180–183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tang Z, Liu Y, He M and Bu W: Chemodynamic
therapy: Tumour microenvironment-mediated fenton and fenton-like
reactions. Angew Chem Int Ed Engl. 58:946–956. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miller CJ, Rose AL and Waite TD:
Importance of iron complexation for fenton-mediated hydroxyl
radical production at circumneutral pH. Front Mar Sci. 3:1342016.
View Article : Google Scholar
|
|
44
|
Yu L, Lin Z, Cheng X, Chu J, Li X, Chen C,
Zhu T, Li W, Lin W and Tang W: Thorium inhibits human respiratory
chain complex IV (cytochrome c oxidase). J Hazard Mater.
424:1275462022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rattanawong K, Koiso N, Toda E, Kinoshita
A, Tanaka M, Tsuji H and Okamoto T: Regulatory functions of ROS
dynamics via glutathione metabolism and glutathione peroxidase
activity in developing rice zygote. Plant J. 108:1097–1115. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Peoples JN, Saraf A, Ghazal N, Pham TT and
Kwong JQ: Mitochondrial dysfunction and oxidative stress in heart
disease. Exp Mol Med. 51:1–13. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Prasad S, Gupta SC and Tyagi AK: Reactive
oxygen species (ROS) and cancer: Role of antioxidative
nutraceuticals. Cancer Lett. 387:95–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang R, Kang KA, Kim KC, Na SY, Chang WY,
Kim GY, Kim HS and Hyun JW: Oxidative stress causes epigenetic
alteration of CDX1 expression in colorectal cancer cells. Gene.
524:214–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang Y, Karakhanova S, Hartwig W, D'Haese
JG, Philippov PP, Werner J and Bazhin AV: Mitochondria and
mitochondrial ROS in cancer: Novel targets for anticancer therapy.
J Cell Physiol. 231:2570–2581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Islam MT: Oxidative stress and
mitochondrial dysfunction-linked neurodegenerative disorders.
Neurol Res. 39:73–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang
XJ, Wang H, Du Y, Guan J, Wang X and Fu J: NAD+ improves
cognitive function and reduces neuroinflammation by ameliorating
mitochondrial damage and decreasing ROS production in chronic
cerebral hypoperfusion models through Sirt1/PGC-1α pathway. J
Neuroinflammation. 18:2072021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Uittenbogaard M, Baxter KK and Chiaramello
A: The neurogenic basic helix-loop-helix transcription factor
NeuroD6 confers tolerance to oxidative stress by triggering an
antioxidant response and sustaining the mitochondrial biomass. ASN
Neuro. 2:e000342010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hou K, Chen Y, Zhu D, Chen G, Chen F, Xu
N, Barakat K, Zheng J, Xie X and Chen R: Curcumin inhibits high
glucose oxidative stress and apoptosis in pancreatic beta cells via
CHOP/PCG-1a and pERK1/2. Front Biosci (Landmark Ed). 25:1974–1984.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tang G, Li S, Zhang C, Chen H, Wang N and
Feng Y: Clinical efficacies, underlying mechanisms and molecular
targets of Chinese medicines for diabetic nephropathy treatment and
management. Acta Pharm Sin B. 11:2749–2767. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Su X, Chu Y, Kordower JH, Li B, Cao H,
Huang L, Nishida M, Song L, Wang D and Federoff HJ: PGC-1α promoter
methylation in Parkinson's disease. PLoS One. 10:e01340872015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li Y, Chen M, Xu Y, Yu X, Xiong T, Du M,
Sun J, Liu L, Tang Y and Yao P: Iron-mediated lysosomal membrane
permeabilization in ethanol-induced hepatic oxidative damage and
apoptosis: Protective effects of quercetin. Oxid Med Cell Longev.
2016:41476102016.PubMed/NCBI
|
|
57
|
Park E and Chung SW: ROS-mediated
autophagy increases intracellular iron levels and ferroptosis by
ferritin and transferrin receptor regulation. Cell Death Dis.
10:8222019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen H, Xu C, Yu Q, Zhong C, Peng Y, Chen
J and Chen G: Comprehensive landscape of STEAP family functions and
prognostic prediction value in glioblastoma. J Cell Physiol.
236:2988–3000. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Song Q, Peng S, Sun Z, Heng X and Zhu X:
Temozolomide drives ferroptosis via a DMT1-dependent pathway in
glioblastoma cells. Yonsei Med J. 62:843–849. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cheung EC and Vousden KH: The role of ROS
in tumour development and progression. Nat Rev Cancer. 22:280–297.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wei S, Qiu T, Yao X, Wang N, Jiang L, Jia
X, Tao Y, Wang Z, Pei P, Zhang J, et al: Arsenic induces pancreatic
dysfunction and ferroptosis via mitochondrial
ROS-autophagy-lysosomal pathway. J Hazard Mater. 384:1213902020.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhou B, Liu J, Kang R, Klionsky DJ,
Kroemer G and Tang D: Ferroptosis is a type of autophagy-dependent
cell death. Semin Cancer Biol. 66:89–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhuang Y, Li T, Xiao H, Wu J, Su S, Dong
X, Hu X, Hua Q, Liu J, Shang W, et al: LncRNA-H19 drives
cardiomyocyte senescence by targeting miR-19a/socs1/p53 axis. Front
Pharmacol. 12:6318352021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C
and Li B: Ferroptosis, a new form of cell death: Opportunities and
challenges in cancer. J Hematol Oncol. 12:342019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. 12:599–620. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang H, He Y, Wang JX, Chen MH, Xu JJ,
Jiang MH, Feng YL and Gu YF: miR-30-5p-mediated ferroptosis of
trophoblasts is implicated in the pathogenesis of preeclampsia.
Redox Biol. 29:1014022020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Liu MR, Zhu WT and Pei DS: System
Xc−: A key regulatory target of ferroptosis in cancer.
Invest New Drugs. 39:1123–1131. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang L, Liu Y, Du T, Yang H, Lei L, Guo M,
Ding HF, Zhang J, Wang H, Chen X and Yan C: ATF3 promotes
erastin-induced ferroptosis by suppressing system Xc. Cell Death
Differ. 27:662–675. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kong R, Wang N, Han W, Bao W and Lu J:
IFNγ-mediated repression of system xc− drives
vulnerability to induced ferroptosis in hepatocellular carcinoma
cells. J Leukoc Biol. 110:301–314. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Floros KV, Cai J, Jacob S, Kurupi R,
Fairchild CK, Shende M, Coon CM, Powell KM, Belvin BR, Hu B, et al:
MYCN-amplified neuroblastoma is addicted to iron and vulnerable to
inhibition of the system Xc-/glutathione axis. Cancer Res.
81:1896–1908. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ding Y, Chen X, Liu C, Ge W, Wang Q, Hao
X, Wang M, Chen Y and Zhang Q: Identification of a small molecule
as inducer of ferroptosis and apoptosis through ubiquitination of
GPX4 in triple negative breast cancer cells. J Hematol Oncol.
14:192021. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Imai H, Matsuoka M, Kumagai T, Sakamoto T
and Koumura T: Lipid peroxidation-dependent cell death regulated by
GPx4 and ferroptosis. Curr Top Microbiol Immunol. 403:143–170.
2017.PubMed/NCBI
|
|
74
|
Li H, Liu W, Zhang X, Wu F, Sun D and Wang
Z: Ketamine suppresses proliferation and induces ferroptosis and
apoptosis of breast cancer cells by targeting KAT5/GPX4 axis.
Biochem Biophys Res Commun. 585:111–116. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Tang X, Ding H, Liang M, Chen X, Yan Y,
Wan N, Chen Q, Zhang J and Cao J: Curcumin induces ferroptosis in
non-small-cell lung cancer via activating autophagy. Thorac Cancer.
12:1219–1230. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang Y, Kong Y, Ma Y, Ni S, Wikerholmen
T, Xi K, Zhao F, Zhao Z, Wang J, Huang B, et al: Loss of COPZ1
induces NCOA4 mediated autophagy and ferroptosis in glioblastoma
cell lines. Oncogene. 40:1425–1439. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bersuker K, Hendricks JM, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang CX, Chen LH, Zhuang HB, Shi ZS, Chen
ZC, Pan JP and Hong ZS: Auriculasin enhances ROS generation to
regulate colorectal cancer cell apoptosis, ferroptosis, oxeiptosis,
invasion and colony formation. Biochem Biophys Res Commun.
587:99–106. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Santoro MM: The antioxidant role of
non-mitochondrial CoQ10: mystery solved! Cell Metab. 31:13–15.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Doll S, Freitas FP, Shah R, Aldrovandi M,
da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius
E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis
suppressor. Nature. 575:693–698. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zheng J and Conrad M: The metabolic
underpinnings of ferroptosis. Cell Metab. 32:920–937. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hu Q, Wei W, Wu D, Huang F, Li M, Li W,
Yin J, Peng Y, Lu Y, Zhao Q and Liu L: Blockade of GCH1/BH4 axis
activates ferritinophagy to mitigate the resistance of colorectal
cancer to erastin-induced ferroptosis. Front Cell Dev Biol.
10:8103272022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Qiu C, Liu T, Luo D, Luan D, Cheng L and
Wang S: Novel therapeutic savior for osteosarcoma: The endorsement
of ferroptosis. Front Oncol. 12:7460302022. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gao M, Fan K, Chen Y, Zhang G, Chen J and
Zhang Y: Understanding the mechanistic regulation of ferroptosis in
cancer: The gene matters. J Genet Genomics. S1673-8527(22)00160-6.
2022.(Epub ahead of print). View Article : Google Scholar
|
|
85
|
Kraft VAN, Bezjian CT, Pfeiffer S,
Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X,
Anastasov N, Kössl J, et al: GTP cyclohydrolase
1/tetrahydrobiopterin counteract ferroptosis through lipid
remodeling. ACS Cent Sci. 6:41–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chew GT and Watts GF: Coenzyme Q10 and
diabetic endotheliopathy: Oxidative stress and the ‘recoupling
hypothesis’. QJM. 97:537–548. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Ilango S, Paital B, Jayachandran P, Padma
PR and Nirmaladevi R: Epigenetic alterations in cancer. Front
Biosci (Landmark Ed). 25:1058–1109. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wu SC and Zhang Y: Active DNA
demethylation: Many roads lead to Rome. Nat Rev Mol Cell Biol.
11:607–620. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Goll MG and Bestor TH: Eukaryotic cytosine
methyltransferases. Annu Rev Biochem. 74:481–514. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lu F, Liu Y, Jiang L, Yamaguchi S and
Zhang Y: Role of Tet proteins in enhancer activity and telomere
elongation. Genes Dev. 28:2103–2119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Jiang J, Yan T and Guo F: Global DNA 5hmC
and CK195hmC+ contents: A promising biomarker for
predicting prognosis in small hepatocellular carcinoma. Curr Oncol.
28:3758–3770. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ito S, Shen L, Dai Q, Wu SC, Collins LB,
Swenberg JA, He C and Zhang Y: Tet proteins can convert
5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.
Science. 333:1300–1303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Hashimoto H, Vertino PM and Cheng X:
Molecular coupling of DNA methylation and histone methylation.
Epigenomics. 2:657–669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Jara-Espejo M and Line SR: DNA
G-quadruplex stability, position and chromatin accessibility are
associated with CpG island methylation. FEBS J. 287:483–495. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Horii T and Hatada I: Regulation of CpG
methylation by Dnmt and Tet in pluripotent stem cells. J Reprod
Dev. 62:331–335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Van Tongelen A, Loriot A and De Smet C:
Oncogenic roles of DNA hypomethylation through the activation of
cancer-germline genes. Cancer Lett. 396:130–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Klutstein M, Nejman D, Greenfield R and
Cedar H: DNA methylation in cancer and aging. Cancer Res.
76:3446–3450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Jair KW, Bachman KE, Suzuki H, Ting AH,
Rhee I, Yen RW, Baylin SB and Schuebel KE: De novo CpG island
methylation in human cancer cells. Cancer Res. 66:682–692. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Mendoza-Pérez J, Gu J, Herrera LA, Tannir
NM, Matin SF, Karam JA, Huang M, Chang DW, Wood CG and Wu X:
Genomic DNA hypomethylation and risk of renal cell carcinoma: A
case-control study. Clin Cancer Res. 22:2074–2082. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhang L, Xiao X and Xu ZC: iPromoter-5mC:
A novel fusion decision predictor for the identification of
5-methylcytosine sites in genome-wide DNA promoters. Front Cell Dev
Biol. 8:6142020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Robert MF, Morin S, Beaulieu N, Gauthier
F, Chute IC, Barsalou A and MacLeod AR: DNMT1 is required to
maintain CpG methylation and aberrant gene silencing in human
cancer cells. Nat Genet. 33:61–65. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Choi SJ, Jung SW, Huh S, Chung YS, Cho H
and Kang H: Alteration of DNA methylation in gastric cancer with
chemotherapy. J Microbiol Biotechnol. 27:1367–1378. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Logie E, Van Puyvelde B, Cuypers B,
Schepers A, Berghmans H, Verdonck J, Laukens K, Godderis L,
Dhaenens M, Deforce D and Vanden Berghe W: Ferroptosis induction in
multiple myeloma cells triggers DNA methylation and histone
modification changes associated with cellular senescence. Int J Mol
Sci. 22:122342021. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Xu Y, Hong M, Kong D, Deng J, Zhong Z and
Liang J: Ferroptosis-associated DNA methylation signature predicts
overall survival in patients with head and neck squamous cell
carcinoma. BMC Genomics. 23:632022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Mao C, Wang X, Liu Y, Wang M, Yan B, Jiang
Y, Shi Y, Shen Y, Liu X, Lai W, et al: A G3BP1-interacting lncRNA
promotes ferroptosis and apoptosis in cancer via nuclear
sequestration of p53. Cancer Res. 78:3484–3496. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Jiang Y, Mao C, Yang R, Yan B, Shi Y, Liu
X, Lai W, Liu Y, Wang X, Xiao D, et al: EGLN1/c-Myc induced
lymphoid-specific helicase inhibits ferroptosis through lipid
metabolic gene expression changes. Theranostics. 7:3293–3305. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhang X, Huang Z, Xie Z, Chen Y, Zheng Z,
Wei X, Huang B, Shan Z, Liu J, Fan S, et al: Homocysteine induces
oxidative stress and ferroptosis of nucleus pulposus via enhancing
methylation of GPX4. Free Radic Biol Med. 160:552–565. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
van Roy F: Beyond E-cadherin: Roles of
other cadherin superfamily members in cancer. Nat Rev Cancer.
14:121–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Tan L and Shi YG: Tet family proteins and
5-hydroxymethylcytosine in development and disease. Development.
139:1895–1902. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Tang Y, Li C, Zhang YJ and Wu ZH:
Ferroptosis-related long non-coding RNA signature predicts the
prognosis of Head and neck squamous cell carcinoma. Int J Biol Sci.
17:702–711. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Wang J, Zhu S, Meng N, He Y, Lu R and Yan
GR: ncRNA-encoded peptides or proteins and cancer. Mol Ther.
27:1718–1725. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Zhang H, Deng T, Liu R, Ning T, Yang H,
Liu D, Zhang Q, Lin D, Ge S, Bai M, et al: CAF secreted miR-522
suppresses ferroptosis and promotes acquired chemo-resistance in
gastric cancer. Mol Cancer. 19:432020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Hill M and Tran N: miRNA interplay:
Mechanisms and consequences in cancer. Dis Model Mech.
14:dmm0476622021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Sengupta D, Deb M, Kar S, Pradhan N,
Parbin S, Kirtana R, Singh SP, Suma SG, Niharika, Roy A, et al:
Dissecting miRNA facilitated physiology and function in human
breast cancer for therapeutic intervention. Semin Cancer Biol.
72:46–64. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Lande K, Gupta J, Ranjan R, Kiran M,
Torres Solis LF, Solís Herrera A, Aliev G and Karnati R: Exosomes:
Insights from retinoblastoma and other eye cancers. Int J Mol Sci.
21:70552020. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Luo M, Wu L, Zhang K, Wang H, Zhang T,
Gutierrez L, O'Connell D, Zhang P, Li Y, Gao T, et al: miR-137
regulates ferroptosis by targeting glutamine transporter SLC1A5 in
melanoma. Cell Death Differ. 25:1457–1472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Tomita K, Nagasawa T, Kuwahara Y, Torii S,
Igarashi K, Roudkenar MH, Roushandeh AM, Kurimasa A and Sato T:
MiR-7-5p is involved in ferroptosis signaling and radioresistance
thru the generation of ROS in radioresistant HeLa and SAS cell
lines. Int J Mol Sci. 22:83002021. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Chen D, Fan Z, Rauh M, Buchfelder M,
Eyupoglu IY and Savaskan N: ATF4 promotes angiogenesis and neuronal
cell death and confers ferroptosis in a xCT-dependent manner.
Oncogene. 36:5593–5608. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Gomaa A, Peng D, Chen Z, Soutto M,
Abouelezz K, Corvalan A and El-Rifai W: Epigenetic regulation of
AURKA by miR-4715-3p in upper gastrointestinal cancers. Sci Rep.
9:169702019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Yu W, Yao J, Lyu P, Zhou J, Chen X, Liu X
and Xiao S: XPG is modulated by miR-4715-3p and rs873601 genotypes
in lung cancer. Cancer Manag Res. 13:3417–3427. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhuang ST, Cai YJ, Liu HP, Qin Y and Wen
JF: LncRNA NEAT1/miR-185-5p/IGF2 axis regulates the invasion and
migration of colon cancer. Mol Genet Genomic Med. 8:e11252020.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Marengo B, Pulliero A, Izzotti A and
Domenicotti C: miRNA regulation of glutathione homeostasis in
cancer initiation, progression and therapy resistance. Microrna.
9:187–197. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Hu X, Miao J, Zhang M, Wang X, Wang Z, Han
J, Tong D and Huang C: miRNA-103a-3p promotes human gastric cancer
cell proliferation by targeting and suppressing ATF7 in vitro. Mol
Cells. 41:390–400. 2018.PubMed/NCBI
|
|
126
|
Zhi Y, Gao L, Wang B, Ren W, Liang KX and
Zhi K: Ferroptosis holds novel promise in treatment of cancer
mediated by non-coding RNAs. Front Cell Dev Biol. 9:6869062021.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Bridges MC, Daulagala AC and Kourtidis A:
LNCcation: lncRNA localization and function. J Cell Biol.
220:e2020090452021. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu
N, Shi Y, Chen L, Xiao D, Yu F, et al: Long noncoding RNA LINC00336
inhibits ferroptosis in lung cancer by functioning as a competing
endogenous RNA. Cell Death Differ. 26:2329–2343. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Wang Y, Li X, Chen W and Wu W: The common
region of lncRNAs UCA1 and UCA1α contributes to the bladder cancer
tumorigenesis. Eur J Cancer Prev. 30:389–392. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Kim S, Kim JE, Kim YH, Hwang T, Kim SK, Xu
WJ, Shin JY, Kim JI, Choi H, Kim HC, et al: Glutaminase 2
expression is associated with regional heterogeneity of
5-aminolevulinic acid fluorescence in glioblastoma. Sci Rep.
7:122212017. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Chen J, Hu Q, Zhang BF, Liu XP, Yang S and
Jiang H: Long noncoding RNA UCA1 inhibits ischaemia/reperfusion
injury induced cardiomyocytes apoptosis via suppression of
endoplasmic reticulum stress. Genes Genomics. 41:803–810. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Shin D, Kim EH, Lee J and Roh JL: Nrf2
inhibition reverses resistance to GPX4 inhibitor-induced
ferroptosis in head and neck cancer. Free Radic Biol Med.
129:454–462. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Yang Y, Tian Q, Wu S, Li Y, Yang K, Yan Y,
Shang L, Li A and Zhang L: Blue light-triggered
Fe2+-release from monodispersed ferrihydrite
nanoparticles for cancer iron therapy. Biomaterials.
271:1207392021. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Xie Z, Hou H, Luo D, An R, Zhao Y and Qiu
C: ROS-dependent lipid peroxidation and reliant antioxidant
ferroptosis-suppressor-protein 1 in rheumatoid arthritis: A covert
clue for potential therapy. Inflammation. 44:35–47. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Xu Y, Luo X, He W, Chen G, Li Y, Li W,
Wang X, Lai Y and Ye Y: Long non-coding RNA PVT1/miR-150/HIG2 axis
regulates the proliferation, invasion and the balance of iron
metabolism of hepatocellular carcinoma. Cell Physiol Biochem.
49:1403–1419. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Zheng J, Zhou Z, Qiu Y, Wang M, Yu H, Wu
Z, Wang X and Jiang X: A prognostic ferroptosis-related lncRNAs
signature associated with immune landscape and radiotherapy
response in glioma. Front Cell Dev Biol. 9:6755552021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Qi W, Li Z, Xia L, Dai J, Zhang Q, Wu C
and Xu S: LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress
during erastin-induced ferroptosis in HepG2 hepatocellular
carcinoma cells. Sci Rep. 9:161852019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L,
Zhang Z, Cai T and Zhu Y: Variant G6PD levels promote tumor cell
proliferation or apoptosis via the STAT3/5 pathway in the human
melanoma xenograft mouse model. BMC Cancer. 13:2512013. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Su X, Yang Y, Yang Q, Pang B, Sun S, Wang
Y, Qiao Q, Guo C, Liu H and Pang Q: NOX4-derived ROS-induced
overexpression of FOXM1 regulates aerobic glycolysis in
glioblastoma. BMC Cancer. 21:11812021. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Wang Z, Ding Y, Wang X, Lu S, Wang C, He
C, Wang L, Piao M, Chi G, Luo Y and Ge P: Pseudolaric acid B
triggers ferroptosis in glioma cells via activation of Nox4 and
inhibition of xCT. Cancer Lett. 428:21–33. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Chen B, Wang H, Lv C, Mao C and Cui Y:
Long non-coding RNA H19 protects against intracerebral hemorrhage
injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long
chain family member 4 axis. Bioengineered. 12:4004–4015. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
He GN, Bao NR, Wang S, Xi M, Zhang TH and
Chen FS: Ketamine induces ferroptosis of liver cancer cells by
targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Des Devel Ther.
15:3965–3978. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Yang Y, Tai W, Lu N, Li T, Liu Y, Wu W, Li
Z, Pu L, Zhao X, Zhang T and Dong Z: lncRNA ZFAS1 promotes lung
fibroblast-to-myofibroblast transition and ferroptosis via
functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging
(Albany NY). 12:9085–9102. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Chen L, Wang C, Sun H, Wang J, Liang Y,
Wang Y and Wong G: The bioinformatics toolbox for circRNA discovery
and analysis. Brief Bioinform. 22:1706–1728. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan
Y, Kong X, Bu J, Liu M and Xu S: circRNA-002178 act as a ceRNA to
promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis.
11:322020. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Li R, Jiang J, Shi H, Qian H, Zhang X and
Xu W: CircRNA: A rising star in gastric cancer. Cell Mol Life Sci.
77:1661–1680. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Liu Z, Wang Q, Wang X, Xu Z, Wei X and Li
J: Circular RNA cIARS regulates ferroptosis in HCC cells through
interacting with RNA binding protein ALKBH5. Cell Death Discov.
6:722020. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhang HY, Zhang BW, Zhang ZB and Deng QJ:
Circular RNA TTBK2 regulates cell proliferation, invasion and
ferroptosis via miR-761/ITGB8 axis in glioma. Eur Rev Med Pharmacol
Sci. 24:2585–2600. 2020.PubMed/NCBI
|
|
150
|
Zhang S, Sun J, Gu M, Wang G and Wang X:
Circular RNA: A promising new star for the diagnosis and treatment
of colorectal cancer. Cancer Med. 10:8725–8740. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Qiao G, Zhang W and Dong K: Regulation of
ferroptosis by noncoding RNAs: A novel promise treatment in
esophageal squamous cell carcinoma. Mol Cell Biochem.
477:2193–2202. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Kinoshita C and Aoyama K: The role of
non-coding RNAs in the neuroprotective effects of glutathione. Int
J Mol Sci. 22:42452021. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Zhang Y, Koppula P and Gan B: Regulation
of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1. Cell
Cycle. 18:773–783. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Wang X, Liu K, Gong H, Li D, Chu W, Zhao
D, Wang X and Xu D: Death by histone deacetylase inhibitor
quisinostat in tongue squamous cell carcinoma via apoptosis,
pyroptosis, and ferroptosis. Toxicol Appl Pharmacol.
410:1153632021. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
He C, Wang C, Liu H and Shan B: Kayadiol
exerted anticancer effects through p53-mediated ferroptosis in
NKTCL cells. BMC Cancer. 22:7242022. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Wang Y, Zhao Y, Wang H, Zhang C, Wang M,
Yang Y, Xu X and Hu Z: Histone demethylase KDM3B protects against
ferroptosis by upregulating SLC7A11. FEBS Open Bio. 10:637–643.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Liu J, Kang R and Tang D: Signaling
pathways and defense mechanisms of ferroptosis. FEBS J. Jun
6–2021.(Epub ahead of print). View Article : Google Scholar
|
|
158
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Kang R, Kroemer G and Tang D: The tumor
suppressor protein p53 and the ferroptosis network. Free Radic Biol
Med. 133:162–168. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Galván I, Inácio Â, Dañino M, Corbí-Llopis
R, Monserrat MT and Bernabeu-Wittel J: High SLC7A11 expression in
normal skin of melanoma patients. Cancer Epidemiol. 62:1015822019.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Sui S, Zhang J, Xu S, Wang Q, Wang P and
Pang D: Ferritinophagy is required for the induction of ferroptosis
by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells.
Cell Death Dis. 10:3312019. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Liu T, Jiang L, Tavana O and Gu W: The
deubiquitylase OTUB1 mediates ferroptosis via stabilization of
SLC7A11. Cancer Res. 79:1913–1924. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Dai X, Lu L, Deng S, Meng J, Wan C, Huang
J, Sun Y, Hu Y, Wu B, Wu G, et al: USP7 targeting modulates
anti-tumor immune response by reprogramming tumor-associated
macrophages in lung cancer. Theranostics. 10:9332–9347. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Wang Y, Yang L, Zhang X, Cui W, Liu Y, Sun
QR, He Q, Zhao S, Zhang GA, Wang Y and Chen S: Epigenetic
regulation of ferroptosis by H2B monoubiquitination and p53. EMBO
Rep. 20:e475632019. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Lin PL, Tang HH, Wu SY, Shaw NS and Su CL:
Saponin formosanin C-induced ferritinophagy and ferroptosis in
human hepatocellular carcinoma cells. Antioxidants (Basel).
9:6822020. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Xiao S, Liu X, Yuan L and Wang F: A
ferroptosis-related lncRNAs signature predicts prognosis and
therapeutic response of gastric cancer. Front Cell Dev Biol.
9:7366822021. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Wang Z, Zhang X, Tian X, Yang Y, Ma L,
Wang J and Yu Y: CREB stimulates GPX4 transcription to inhibit
ferroptosis in lung adenocarcinoma. Oncol Rep. 45:882021.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Zilka O, Poon JF and Pratt DA:
Radical-trapping antioxidant activity of copper and nickel
Bis(Thiosemicarbazone) complexes underlies their potency as
inhibitors of ferroptotic cell death. J Am Chem Soc.
143:19043–19057. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Hassannia B, Vandenabeele P and Vanden
Berghe T: Targeting ferroptosis to iron out cancer. Cancer Cell.
35:830–849. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Poon JF and Pratt DA: Recent insights on
hydrogen atom transfer in the inhibition of hydrocarbon
autoxidation. Acc Chem Res. 51:1996–2005. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Wang SJ, Li D, Ou Y, Jiang L, Chen Y, Zhao
Y and Gu W: Acetylation is crucial for p53-mediated ferroptosis and
tumor suppression. Cell Rep. 17:366–373. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Nakamura T, Naguro I and Ichijo H: Iron
homeostasis and iron-regulated ROS in cell death, senescence and
human diseases. Biochim Biophys Acta Gen Subj. 1863:1398–1409.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Luo Y, Huang Q, He B, Liu Y, Huang S and
Xiao J: Regulation of ferroptosis by non-coding RNAs in the
development and treatment of cancer (Review). Oncol Rep. 45:29–48.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Pei Y, Qian Y, Wang H and Tan L:
Epigenetic regulation of ferroptosis-associated genes and its
implication in cancer therapy. Front Oncol. 12:7718702022.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Moloney JN and Cotter TG: ROS signalling
in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Wu Y, Zhang S, Gong X, Tam S, Xiao D, Liu
S and Tao Y: The epigenetic regulators and metabolic changes in
ferroptosis-associated cancer progression. Mol Cancer. 19:392020.
View Article : Google Scholar : PubMed/NCBI
|
